Novartis’ Xolair backed in global urticaria guidelines

6th March 2018 Uncategorised 0

Novartis’ Xolair has been recommended in global guidelines for treating chronic spontaneous urticaria in patients unresponsive to antihistamines.

More: Novartis’ Xolair backed in global urticaria guidelines
Source: News